# IRulya Therapeutics Inc.: Form 8-K, filed Oct 17, 2025

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2025-10-17
- Accepted by EDGAR: Oct 17, 2025, 20:11 ET
- Period: 2025-10-17
- Accession: 0001193125-25-242514
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312525242514/d75404d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312525242514/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312525242514/d75404d8k.htm

Filed Oct 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-242514. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.